Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patients

BACKGROUND: Efficacy trials suggest that extra-fine particle beclometasone dipropionate-formoterol (efBDP-FOR) is comparable to fluticasone propionate-salmeterol (FP-SAL) in preventing asthma exacerbations at a clinically equivalent dosage. However, switching from FP-SAL to efBDP-FOR has not been ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, David, Small, Iain, Haughney, John, Ryan, Dermot, Gruffydd-Jones, Kevin, Lavorini, Federico, Harris, Tim, Burden, Annie, Brockman, Jeremy, King, Christine, Papi, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443103/
https://www.ncbi.nlm.nih.gov/pubmed/24186700
http://dx.doi.org/10.4104/pcrj.2013.00088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443103/
https://www.ncbi.nlm.nih.gov/pubmed/24186700
http://dx.doi.org/10.4104/pcrj.2013.00088

Ejemplares similares